In particular, in at least one report, specific monocyte sub-types have elevated LRRK2 in PD patients and release inflammatory cytokines to a greater extent in PD patients than in healthy controls following stimulation (Bliederhaeuser et al., 2016; Cook et al., 2017). The gene discussed is LRRK2; the disease is Parkinson disease.